Burning Rock Biotech Investor Relations Material
Latest events
Q1 2024
Burning Rock Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Burning Rock Biotech Limited
Access all reports
Burning Rock Biotech Limited focuses on developing and providing next-generation sequencing-based cancer therapy selection tests. The company offers comprehensive genomic profiling services and products for cancer patients to guide treatment decisions. Its key services include liquid biopsy, tissue biopsy, and companion diagnostic development, aimed at improving clinical outcomes for cancer patients. Burning Rock Biotech serves sectors such as oncology, biotechnology, and personalized medicine, collaborating with medical institutions, pharmaceutical companies, and research organizations. The company is headquartered in Guangzhou, China, and its shares are listed on the NASDAQ.
Key slides for Burning Rock Biotech Limited
Q4 2024
Burning Rock Biotech Limited
Q4 2024
Burning Rock Biotech Limited
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
BNR
Country
🇺🇸 United States